PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy
Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-15
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter, randomized controlled clinical study to evaluate the efficacy of PCSK9 inhibitor in addition to standard therapy in patients with acute ischemic stroke undergoing endovascular therapy.